Could cause temporary or reversible harm; serious harm is unlikely.
Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.
| Brand name | ICOSAPENT ETHYL |
| Generic name | ICOSAPENT ETHYL |
| Active ingredient(s) | ICOSAPENT ETHYL |
| Distributed by / for | Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534 |
| NDC | 70710-1592-7 |
| Full product label | Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7. |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | IL, PA, & MS |
| Quantity | 11,616 bottles |
| Recall initiated | 2025-05-30 |
| Report date | 2025-06-18 |
| Recall completed | — |
| Recall number | D-0497-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗